Back to results
US 5,854,211 AGranted
Compounds with growth hormone releasing properties
AssigneeNovo Nordisk A/S
InventorsNils Langeland Johansen, Jesper Lau, Kjeld Madsen, Behrend Friedrich Lundt, Henning Th.o slashed.gersen, Birgit Sehested Hansen
Life of this patent
Estimating the term…
Abstract
Novel peptide derivatives, compositions containing them, and their use for treating medical disorders resulting from a deficiency in growth hormone are disclosed. These peptide derivatives have the formula: A--B--C--D--E (--F).sub.p wherein A, B, C, D, E, F and p are as defined in the specification. These peptides exhibit improved resistance to proteolytic degradation as well as improved growth hormone releasing activity.
Claims15
A compound of general formula I
- A--B--C--D--E (--F).sub.p
- wherein
- p is 0 or 1;
- A is imidazolyl-C.sub.1-6 alkanoic acid, imidazolyl-C.sub.1-6 alkenoic acid, amino-C.sub.1-6 alkanoic acid or amino-C.sub.1-6 alkenoic acid or a L- or D- .alpha.-amino acid selected from the group consisting of H-His, H-Ala, H-D-Ala, H-.beta.-alanine, H-amino-isobutyric acid, sarcosine and Gly;
- B is D-Trp, D-2Nal or D-Phe;
- C is Ala, Ser or Gly;
- D is Trp, Phe, .beta.-(2-Thienyl)-alanine or N-aralkyl glycine;
- E, when p is 1, is D-Phe, or, when p is 0, E is --NH--CH(CH.sub.2 --R.sup.3)--CO--R.sup.4 or --NH--CH(CH.sub.2 --R.sup.3)--CH.sub.2 --R.sup.4, wherein
- R.sup.3 is phenyl,
- and R.sup.4 is piperazino, morpholino, piperidino, --OH or --N(R.sup.5)R.sup.6, wherein each of R.sup.5 and R.sup.6 is independently hydrogen or lower alkyl;
- F, when p is 1, is --NH--CH(R.sup.10)--(CH.sub.2)R.sup.7, wherein
- v is 0 or an integer between 1 and 8, and
- R.sup.7 is imidazolyl, piperazino, morpholino, piperidino or --N(R.sup.8)--R.sup.9, wherein each of R.sup.8 and R.sup.9 is independently hydrogen or lower alkyl, or the Amadori rearrangement product from an amino group and a hexapyranose or a hexapyranosyl-hexapyranose, ##STR7## and R.sup.10 is --H, --COOH, --CO--R.sup.11, CH.sub.2 --R.sup.11 or --CH.sub.2 --OH, wherein R.sup.11 is piperazino, morpholino, piperidino or --N(R.sup.12)--R.sup.13, wherein each of R.sup.12 and R.sup.13 is independently hydrogen or lower alkyl;
- with the proviso that at least one amide bond between A and B, B and C, C and D, D and E or, when p is 1, E and F, is substituted by aminomethylene or that, when p is 0, E is --NH--CH(CH.sub.2 --R.sup.3)--CH--R.sup.4 or that, when p is 1, R.sup.10 is CH.sub.2 --R.sup.11 ;
- or a pharmaceutically acceptable salt thereof.
12 more elements
Dependencies are inferred from the claim text.